Patents/Assignees

SHANGRAO CONCORD PHARMACEUTICAL CO., Ltd.

2 patents in portfolio

US12270124utility2025
Method for Screening Protease Variant and Obtained Protease Variant
0 cites
US11919936utility2024
TEV Protease Variant, Fusion Protein Thereof, Preparation Method Therefor and Use Thereof
0 cites